Skip to main content
. Author manuscript; available in PMC: 2022 Dec 12.
Published in final edited form as: J Cancer Educ. 2021 Aug;36(4):693–701. doi: 10.1007/s13187-020-01690-9

Table 4.

Cervical cancer screening initiation and frequency by demographic and practice characteristics

Total Main parameter for initiating cervical cancer screening If responded time since first sexual activity. How long after first sexual activity do you start screening? How often do you recommend routine cervical cancer screening?



N (%) Age n (%) Time since first sexual activity n (%) Patient request n (%) p value3 N (%) < 1 year n (%) 1 year n (%) > 1 year n (%) p value Every 6 months Annually 1 year p value
Age 0.17 0.75 0.26
 <40 96 (47.5) 11 (11.5) 81 (84.4) 4 (4.2) 81 (46.3) 41 (50.6) 35 (43.2) 5 (6.2) 31 (32.3) 59 (61.5) 6 (6.3)
 >40 106 (52.5) 5 (4.7) 7 (6.6) 94 (88.7) 94 (53.7) 52 (55.3) 38 (40.4) 4 (4.3) 39 (36.8) 65 (61.3) 2 (1.9)
Sex p = 0.20 0.09 0.24
 Male 66 (32.7) 8 (12.1) 56 (84.8) 2 (3.0) 56 (32.0) 23 (41.1) 29 (51.8) 4 (7.1) 18 (27.3) 46 (69.7) 2(3)
 Female 136 (67.3) 8 (5.9) 119 (87.5) 9 (6.6) 119 (68.0) 70 (58.8) 44 (37.0) 5 (4.2) 52 (38.2) 78 (57.4) 6 (4.4)
Years in practice 0.04 0.86 0.06
 <10 years 78 (38.6) 11 (14.1) 63 (80.8) 4 (5.1) 63 (36.0) 32 (50.8) 28 (44.4) 3 (4.8) 23 (29.5) 49 (62.8) 6 (7.7)
 >10 years 124 (61.4) 5 (4.0) 112 (90.3) 7 (5.6) 112 (64.0) 61 (54.5) 45 (40.2) 6 (5.4) 47 (37.9) 75 (60.5) 2 (1.6%)
Practice setting 0.35 0.46 0.75
 Public 154 (76.2) 14 (9.1) 133 (86.4) 7 (4.5) 133 (76.0) 74 (55.6) 52 (39.1) 7 (5.3) 53 (34.4) 94 (61.0) 7 (4.5)
 Private 48 (23.8) 2 (4.2) 42 (87.5) 4 (8.3) 42 (24.0) 19 (45.2) 21 (50.0) 2 (4.8) 17 (35.4) 30 (62.5) 1 (2.1)
Medical specialty 0.01 0.03 0.48
 GYN specialist 101 (50.0) 5 (5.0) 90 (89.1) 6 (5.9) 90 (51.4) 44 (48.9) 41 (45.6) 5 (5.6) 36 (35.6) 60 (59.4) 5 (5.0)
 Non-specialist 50 (24.8) 1 (2.0) 47 (94.0) 2 (4.0) 47 (26.9) 34 (72.3) 12 (25.5) 1 (2.1) 19 (38.0) 31 (62.0) 0 (0.0)
 Ob/gyn resident 51 (25.2) 10 (19.6) 38 (74.5) 3 (5.9) 38 (21.7) 15 (39.5) 20 (52.6) 3 (7.9) 15 (29.4) 33 (64.7) 3 (5.9)
Practice location 0.22 0.03 0.36
 Santo Domingo 172 (85.1) 16 (9.3) 147 (85.5) 9 (5.2) 147 (84.0) 72 (49.0) 66 (44.9) 9 (6.1) 56 (32.6) 109 (63.4) 7 (4.1)
 Monte Plata 30 (14.9) 0 (0.0) 28 (93.3) 2 (6.7) 28 (16.0) 21 (75.0) 7 (25.0) 0 (0.0) 14 (46.7) 15 (50.0) 1 (3.3)
Patients come from... 0.60 0.54 0.53
 Rural areas 16 (7.9) 0 (0.0) 15 (93.8) 1 (6.3) 15 (8.6) 11 (73.3) 4 (26.7) 0 (0.0) 8 (50.0) 8 (50.0) 0 (0.0)
 Urban areas 98 (48.5) 8 (8.2) 83 (84.7) 7 (7.1) 83 (47.4) 43 (51.8) 35 (42.2) 5 (6.0) 32 (32.7) 63 (64.3) 3 (3.1)
 Both 88 (43.6) 8 (9.1) 77 (87.5) 3 (3.4) 77 (44.0) 39 (50.6) 34 (44.2) 4 (5.2) 30 (34.1) 53 (60.2) 5 (5.7)
GUIDELINES
 Follow WHO 0.67 0.80 0.18
  WHO no 75 (37.1) 5 (6.7) 67 (89.3) 3 (4.0) 67 (38.3) 34 (50.7) 30 (44.8) 3 (4.5) 20 (26.7) 52 (69.3) 3 (4.0)
  WHO yes 127(62.9) 11 (8.7) 108 (85.0) 8(6.3) 108 (61.7) 59 (54.6) 43 (39.8) 6 (5.6) 50 (39.4) 72 (56.7) 5(3.9)
 Follow DR norms 0.64 0.49 0.67
  DR norms no 81 (40.1) 8 (9.9) 68 (84.0) 5 (6.2) 68 (38.9) 37 (54.4) 26 (38.2) 5 (7.4) 30 (37.0) 47 (58.0) 4 (4.9)
  DR norms yes 121 (59.9) 8 (6.6) 107 (88.4) 6 (5.0) 107 (61.1) 56 (52.3) 47 (43.9) 4 (3.7) 40 (33.1) 77 (63.6) 4 (3.3)
 Follow ASCCP 0.01 0.50 0.54
  ASCCP no 174 (86.1) 10 (5.7) 155 (89.1) 10 (5.7) 155 (88.0) 84 (54.2) 64 (41.3) 7 (4.5) 62 (35.6) 106 (60.9) 6 (3.4)
  ASCCP yes 28 (13.9) 6 (21.4) 20 (71.4) 2 (7.1) 20 (11.4) 9 (45.0) 9 (45.0) 2 (10.0) 8 (28.6) 18 (64.3) 2 (7.1)
3

Pearson’s χ2 unless otherwise indicated